Digg StumbleUpon LinkedIn YouTube Flickr Facebook Twitter RSS Reset
Comments Off

HEMATOLOGY MCQ – Exercise 36

The multiple choice questions in this online test paper focuses on HEMATOLOGY MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online HEMATOLOGY MCQ Test Paper will help you to evaluate your exam preparation.


1- This online MCQ practice test paper contains 22 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. risk of warfarin embryopathy is greatest in which trimester of pregnancy


Q 2. oral anticoagulants include


Q 3. patients on warfarin with serious bleeding are treated with


Q 4. Purple Toe syndrome is seen in patients receiving warfarin with


Q 5. half life of urokinase is


Q 6. true regarding streptokinase


Q 7. streptokinase binds to which of the following


Q 8. fibrin specific plasminogen activators include


Q 9. urokinase derived from


Q 10. for prevention or treatment of thrombosis in pregnancy following can be given during pregnancy


Q 11. warfarin induced skin necrosis occurs in which week of therapy


Q 12. warfarin embryopathy is due to effect of warfarin on which bone matrix protein


Q 13. initial treatment with warfarin is supported by concomitant administration of which of the following


Q 14. true regarding streptokinase


Q 15. bolus fibrinolytic agent includes


Q 16. recombinant derivative of recombinant tissue type plasminogen activator (rt-PA) is


Q 17. Paget-Schroetter syndrome relates to


Q 18. true statement regarding warfarin


Q 19. risk of intracranial hemorrhage with use of thrombolytic agents is increased in all except


Q 20. warfarin induced skin necrosis is seen in patients with congenital or acquired deficiencies of


Q 21. half life of t-PA (tissue plasminogen activator) is


Q 22. following is direct fibrinolytic agent


Comments are closed.